Skip to content

Apotheek De Stoop Deinze

Active
Private limited companyfounded 2012active for 14 yearsTolpoortstraat 74, 9800 Deinze, BelgiumKBO/BCE: BE 0845.003.424
Summary

Apotheek De Stoop Deinze has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €523,840 and a net result of €85,423. Equity has been stable since 2018 (±1.1% per year). Its solvency ranks better than 76% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 22-03-2012 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.209.068.595 9800 Deinze, since 04-04-2012
Financial year end
31 December
Peppol
Reachable since 10-05-2025

Board and ownership

Board
  • Pharmacell BVDirector · since 06-01-2020
Shareholders

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€347,612
▲ 15.6%
Turnover
≈ €1.3m
estimated
Profit
€85,423
▲ 53.9%
Equity
€523,840
▲ 19.5%
Total assets
€837,549
▲ 5.0%
Employees on 31-12-2025
3
=
Score breakdownlowers riskLiquidity: current ratio 2.88, cash €320,357Equity €523,840 (62.5% of total assets)Figures for financial year 2025 (filed on 16-07-2026)Founded in 2012Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 78% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 88+8
equity 62.5% of total assets
Liquidity 87+8
short-term debt 27.3% · cash 38.2%
Profitability 81+4
return on assets 10.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: 0.1%▲ +0.1 percentage points vs 03-2025 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.88 (2.42 in 2024), above the usual 1.5. Short-term debt is 27.3% and cash 38.2% of total assets. 37.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 75% of them on solvency, 89% on liquidity, 74% on profitability and 72% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 2.88, cash €320,357
NBB · annual accounts
lowers risk · Equity €523,840 (62.5% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 16-07-2026)
NBB · annual accounts
lowers risk · Founded in 2012
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €523,840
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
15 days early
2024
30 days early
2023
26 days early
2022
24 days late
2021
12 days late
2020
27 days late
2019
24 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 5 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €85,423 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as Apotheek De Stoop Deinze: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €766,000 and €876,000, founded between 2009 and 2012.

CompanyTotal assetsGross margin
Apotheek De Stoop Deinze Deinze€837,549€347,612
APOTHEEK JOOSEN Wommelgem€875,867€322,076
Apotheek De Brabanter Jim Pajottegem€765,675€336,139
GS PHARMA Dilbeek€796,930€299,272
APOTHEEK L. DE BOLLE Ninove€802,923€334,854
APOTHEEK DU FAUX - MERELBEKE Merelbeke-Melle€868,927€354,852
Apotheek Van den Berghe Merelbeke-Melle€787,581€350,327
Full comparison

Key facts about Apotheek De Stoop Deinze

What is the company number of Apotheek De Stoop Deinze?
The company number of Apotheek De Stoop Deinze is 0845.003.424. The VAT number is the same number with BE in front: BE 0845.003.424.
Where is Apotheek De Stoop Deinze based?
The registered office is at Tolpoortstraat 74, 9800 Deinze.Company details
What does Apotheek De Stoop Deinze do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek De Stoop Deinze?
The legal form of Apotheek De Stoop Deinze is Private limited company (BV).
When was Apotheek De Stoop Deinze founded?
Apotheek De Stoop Deinze was founded on 22-03-2012.
Is Apotheek De Stoop Deinze still active?
Yes, Apotheek De Stoop Deinze is an active enterprise in the KBO register.
How many employees does Apotheek De Stoop Deinze have?
Apotheek De Stoop Deinze had an average of 2.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek De Stoop Deinze fall under?
In its 2025 annual accounts, Apotheek De Stoop Deinze states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of Apotheek De Stoop Deinze?
The turnover in financial year 2025 is ≈ €1.3m. This figure is estimated from the gross margin of €347,612 and 47 comparable companies (NACE 477). It probably lies between €980,000 and €2.1m.
Is Apotheek De Stoop Deinze profitable?
In financial year 2025, Apotheek De Stoop Deinze made a profit of €85,423.
Where can I find the annual accounts of Apotheek De Stoop Deinze?
Apotheek De Stoop Deinze filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek De Stoop Deinze due?
Apotheek De Stoop Deinze must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.